Life Briefing: CDC Stops Testing for Rabies, Pox Viruses Strategic angle: When medical misinformation wins, testing an antidepressant for meth use, and other health news. Editorial Staff Apr 2
Life Briefing: STAT+: ‘Takeover Tuesday’ saves biotech’s quarter Strategic angle: How 'Takeover Tuesday' saved biotech's first quarter. Editorial Staff Apr 2
Life Briefing: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device? Strategic angle: An analysis of AI-powered devices that received FDA's 'breakthrough' label shows a preference for big-picture, multi-problem solutions. Editorial Staff Apr 2
Life Briefing: Opinion: Medical misinformation wins when patients can’t see their doctors Strategic angle: Desperate patients, unable to get timely doctors’ appointments, seek help wherever they can find it. Editorial Staff Apr 2
Life Briefing: Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like? Strategic angle: Prevention is normally relegated to the periphery of national medical conferences. Not anymore. Editorial Staff Apr 2
Life Briefing: STAT reporter goes up against radiologists to spot deepfake X-rays Strategic angle: A STAT reporter challenges radiologists in identifying deepfake X-rays in this week's STATus Report. Editorial Staff Apr 2
Life Briefing: Trump Administration Prepares 100% Tariffs on Some Imported Drugs Strategic angle: The White House is readying a 100% tax on some imported medicines, a draft order shows. Editorial Staff Apr 2
Life Briefing: Makary Marks One Year at FDA with Focus on Achievements Strategic angle: The FDA commissioner praised staff and listed his accomplishments in a speech to workers. Editorial Staff Apr 1
Life Briefing: Large AI Scribe Study Finds Modest Time Savings for Doctors Strategic angle: A new study reveals that AI scribes saved doctors approximately 16 minutes during an eight-hour shift across five academic medical centers. Editorial Staff Apr 1
Life Briefing: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest Strategic angle: A new review reveals the FDA's shortcomings in disclosing financial conflicts of interest among advisory committee members. Editorial Staff Apr 1
Life Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill. Editorial Staff Apr 1
Life Briefing: Policy Tracker: Exceptions to State Abortion Bans and Early Gestational Limits Strategic angle: This policy tracker documents exceptions in each state’s most restrictive gestational limit or total ban. Editorial Staff Apr 1
Life Briefing: Insilico Medicine CEO on Best Practices for AI in Drug Development Strategic angle: Insights from Alex Zhavoronkov on becoming a productive biotech AI company. Editorial Staff Apr 1
Life Briefing: Novo’s subscription model raises questions about pharma-telehealth tie-ups Strategic angle: A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more Editorial Staff Apr 1
Life Briefing: FDA Moves Toward Allowing Injectable Peptide Compounding Strategic angle: The FDA is reconsidering its stance on compounding pharmacies, potentially allowing the production of injectable peptides previously banned due to safety concerns. Editorial Staff Apr 1
Life Briefing: KFF Health Tracking Poll: The Public’s View of Immigration Enforcement Activities in Health Care Settings Strategic angle: A majority of the public expresses concern over immigration enforcement in hospitals amid policy changes. Editorial Staff Apr 1
Life Briefing: Can a psychedelic ‘coach’ make ketamine therapy even more effective? Strategic angle: A new study explores whether incorporating psychotherapy with ketamine treatment enhances its effectiveness. Editorial Staff Apr 1
Life Briefing: NIH Director's Invocation of Vannevar Bush's Legacy Sparks Pushback Strategic angle: Jay Bhattacharya's claim linking Trump administration policies to Vannevar Bush's vision has ignited controversy. Editorial Staff Apr 1
Life Briefing: Opinion: Medical marijuana should not be recommended for PTSD, anxiety, or depression Strategic angle: “Rigorously derived evidence for the medical efficacy of marijuana is thin,” writes Kevin Sabet. Editorial Staff Apr 1
Life Briefing: Opinion: Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene Strategic angle: Medicare is restricting care for 1 million Americans based on a faulty assumption. Editorial Staff Apr 1